Derleme
BibTex RIS Kaynak Göster

Biofilm formation mechanism in fungi

Yıl 2020, Cilt: 4 Sayı: 2, 116 - 120, 15.11.2020
https://doi.org/10.30616/ajb.778072

Öz

The biofilm problem is a problem that is commonly encountered in many areas of industry and causes serious economic losses. It is stated in the literature that biofilms can be removed from surfaces by appropriate cleaning methods. However, biofilm formation gains continuity over time. Biofilm studies are generally on bacteria. Microorganisms that cause infection in humans include bacteria, viruses, and fungi. In biofilm-borne infections, there may be only one or a combination of various microorganisms. Nowadays, new searches are in progress due to the ineffectiveness of synthetic drugs against fungal diseases, their side effects, and the increase of the number of pathogenic microorganisms that are rapidly resistant to existing antifungals. Therefore, the prevention of biofilm formation is now one of the most important studies worldwide.

Kaynakça

  • Akan E, Kınık Ö (2014). Biyofilm oluşum mekanizması ve biyofilmlerin gıda güvenliğine etkisi. Gıda ve Yem Bilimi - Teknolojisi Dergisi 14: 42- 51.
  • Al-Hatmi AM, Normand AC, Ranque S, Piarroux R , Meletiadis JF, Meis J (2016). Comparative evaluation of Etest, EUCAST, and CLSI methods for amphotericin B, voriconazole, and posaconazole against clinically relevant Fusarium species. Antimicrobial Agents Chemotherapy 2016: 61(1).
  • Andersen KS, Bojsen R, Sorensen LGR, Nielsen M, Lisby M, Folkesson A, Regenberg B (2014). Genetic basis for Saccharomyces cerevisiae biofilm in liquid medium. Genetics, 4(9): 1671-1680.
  • Allison DG, Lappin-Scott HM, Wilson M (2000). Bacterial biofilms in human gastrointestinal Community Structure and Cooperation in Biofilms. Cambridge University Press: .p.65-85.
  • Baillie GS, Douglas LJ (2000). Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. Journal of Antimicrobial Chemotherapy 46: 397-403.
  • Brooks JD, Flint SH (2008). Biofilms in the food industry: Problems and potential Solutions. International Journal of Food Science Technology 43: 2163-76.
  • Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA (2001). Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance. Journal of Bacteriology 183: 5385-94.
  • Chen H, Fujita Q, Feng JC, Fink GR (2004). Tyrosol is a quorum sensing molecule in Candida albicans, Proceedings Naturaes. Academia Sciense 101: 5048-5052.
  • Costerton JW, Stewart PS, Greenberg EP (1999). Bacterial biofilms: a common cause of persistent infections. Science 284(5418): 1318-22.
  • D’Acunto B, frunzo L, Klapper I, Mattei M (2015). Modeling multispecies biofilms including new bacterial species invasion. Mathematical Biosciences 259: 20-6.
  • Dimakopoulou-Papazoglou, D, Lianou A, Koutsoumanis KP (2016). Modelling biofilm formation of Salmonella enterica ser. Newport as a function of pH and water activity. Food Microbiology 53: 76-81.
  • Douglas LJ (2002). Medical importance of biofilms in Candida infections. Revista Iberoamericana Micologia 19: 139-43. Fleming D, Rumbaugh KP (2017). Approaches to dispersing medical biofilms. Microorganisms 5(2): 15.
  • Güvense NC, Ekmekcioğlu S (2016). Biyofilm kontrolünde biyositler ve etki tarzları. Mikrobiyoloji Dergisi 14: 1-19.
  • Hornby JM, Jacobitz-Kizzier SM, McNeel DJ, Jensen EC, Treves DS, Nickerson KW (2004). Inoculum size effect in dimorphic fungi: extracellular control of yeast-mycelium dimorphism in Ceratocystis ulmi. Applied and Environmental Microbiology 70: 1356-1359.
  • Kumamoto CA (2011). Inflammation and gastrointestinal Candida colonization. Current Opinion in Microbiology 14(4):386-91.
  • Laffey SF, Butler G (2005). Phenotype switching affects biofilm formation by Candida parapsilosis. Microbiology 151: 1073-1081.
  • Pascual A (2002). Pathogenesis of catheter-related infections: Lessons for new designs. Clinical Microbiology Infectious 8: 256-64.
  • Pittet D, Li N, Woolson RF, Wenzel RP (1997). Microbiological factors influencing the outcome of nosocomial bloodstream infections: A 6-year validated, population-based model. Clinical Infectious Diseases 24:1068-78.
  • Ramage G, Jose A, Coco B, Rajendran R, Rautemaa R, Murray C, Lappin D, Bagg J (2011). Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro. Oral Surgery Oral Medicine Oral Pathology Oral Radiology Endoddontics 111(4): 456-60.
  • Semighini CP, Hornby JM, Dumitru R, Nickerson KW, Haris SD (2006). Farnesol induced apoptosis in Aspergillus nidulans reveals a possible mechanism for antagonistic interactions between fungi. Moleculer Microbiology 59: 753-764.
  • Shchepin R, Dumitru R, Nickerson KW, Lund M, Dussault PH (2005). Biologically active fluorescent farnesol analogs. Chemistry Biological 12: 639-641.
  • Shchepin R, Hornby JM, Burger E, Niessen T, Dussault P, Nickerson KW (2003). Quorum sensing in Candida albicans: probing farnesol's mode of action with 40 natural and synthetic farnesol analogs. Chemistry Biological 10: 743-750.
  • Simões M, Simões LC, Vieira MJ (2010). A review of current and emergent biofilm control strategies. Food Science and Technology 43: 573-83.
  • Szafrański, SP, Winkel, A., Stiesch, M (2017). The use of bacteriophages to biocontrol oral biofilms. Journal of Biotechnology 250: 29-44.
  • Van Houdt R, Michiels CW (2010). Biofilm formation and the food industry, a fcus on the bacterial outer surface. Journal of Applied Microbiology 109: 1117-31.
  • Westwater C, Balish E, Schofield DA (2005). Candida albicans-conditioned medium protects yeast cells from oxidative stress: a possible link between quorum sensing and oxidative stress resistance. Eukaryot Cell 4: 1654-1661.

Mantarlarda biyofilm oluşum mekanizması

Yıl 2020, Cilt: 4 Sayı: 2, 116 - 120, 15.11.2020
https://doi.org/10.30616/ajb.778072

Öz

Biyofilm sorunu endüstrinin birçok alanında yaygın olarak rastlanılan bir sorundur ve ciddi anlamda ekonomik kayıplara neden olmaktadır. Literatürde uygun temizleme yöntemleri ile biyofilmlerin yüzeylerden uzaklaştırılabileceği belirtilmektedir. Ancak zamanla biyofilm oluşumu süreklilik kazanır. Biyofilm çalışmalarının geneli bakteriler üzerinedir. İnsanlarda enfeksiyona neden olan mikroorganizmalar arasında bakteriler, virüsler ve funguslar bulunmaktadır. Biyofilm kaynaklı enfeksiyonlarda etken tek olabileceği gibi bazı mikroorganizmaların karışımıda olabilir. Günümüzde artan fungal hastalıklara karşı sentetik yapılı ilaçların yetersiz kalması, yan etkileri ve mevcut antifungallere hızla direnç kazanan patojen mikroorganizmaların sayısının artması ile yeni arayışlar devam etmektedir. Bütün bunlara bağlı olarak da biyofilm oluşumunun önlenmesi artık tüm dünyada önem arz eden çalışmaların başında gelmektedir.

Kaynakça

  • Akan E, Kınık Ö (2014). Biyofilm oluşum mekanizması ve biyofilmlerin gıda güvenliğine etkisi. Gıda ve Yem Bilimi - Teknolojisi Dergisi 14: 42- 51.
  • Al-Hatmi AM, Normand AC, Ranque S, Piarroux R , Meletiadis JF, Meis J (2016). Comparative evaluation of Etest, EUCAST, and CLSI methods for amphotericin B, voriconazole, and posaconazole against clinically relevant Fusarium species. Antimicrobial Agents Chemotherapy 2016: 61(1).
  • Andersen KS, Bojsen R, Sorensen LGR, Nielsen M, Lisby M, Folkesson A, Regenberg B (2014). Genetic basis for Saccharomyces cerevisiae biofilm in liquid medium. Genetics, 4(9): 1671-1680.
  • Allison DG, Lappin-Scott HM, Wilson M (2000). Bacterial biofilms in human gastrointestinal Community Structure and Cooperation in Biofilms. Cambridge University Press: .p.65-85.
  • Baillie GS, Douglas LJ (2000). Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. Journal of Antimicrobial Chemotherapy 46: 397-403.
  • Brooks JD, Flint SH (2008). Biofilms in the food industry: Problems and potential Solutions. International Journal of Food Science Technology 43: 2163-76.
  • Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA (2001). Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance. Journal of Bacteriology 183: 5385-94.
  • Chen H, Fujita Q, Feng JC, Fink GR (2004). Tyrosol is a quorum sensing molecule in Candida albicans, Proceedings Naturaes. Academia Sciense 101: 5048-5052.
  • Costerton JW, Stewart PS, Greenberg EP (1999). Bacterial biofilms: a common cause of persistent infections. Science 284(5418): 1318-22.
  • D’Acunto B, frunzo L, Klapper I, Mattei M (2015). Modeling multispecies biofilms including new bacterial species invasion. Mathematical Biosciences 259: 20-6.
  • Dimakopoulou-Papazoglou, D, Lianou A, Koutsoumanis KP (2016). Modelling biofilm formation of Salmonella enterica ser. Newport as a function of pH and water activity. Food Microbiology 53: 76-81.
  • Douglas LJ (2002). Medical importance of biofilms in Candida infections. Revista Iberoamericana Micologia 19: 139-43. Fleming D, Rumbaugh KP (2017). Approaches to dispersing medical biofilms. Microorganisms 5(2): 15.
  • Güvense NC, Ekmekcioğlu S (2016). Biyofilm kontrolünde biyositler ve etki tarzları. Mikrobiyoloji Dergisi 14: 1-19.
  • Hornby JM, Jacobitz-Kizzier SM, McNeel DJ, Jensen EC, Treves DS, Nickerson KW (2004). Inoculum size effect in dimorphic fungi: extracellular control of yeast-mycelium dimorphism in Ceratocystis ulmi. Applied and Environmental Microbiology 70: 1356-1359.
  • Kumamoto CA (2011). Inflammation and gastrointestinal Candida colonization. Current Opinion in Microbiology 14(4):386-91.
  • Laffey SF, Butler G (2005). Phenotype switching affects biofilm formation by Candida parapsilosis. Microbiology 151: 1073-1081.
  • Pascual A (2002). Pathogenesis of catheter-related infections: Lessons for new designs. Clinical Microbiology Infectious 8: 256-64.
  • Pittet D, Li N, Woolson RF, Wenzel RP (1997). Microbiological factors influencing the outcome of nosocomial bloodstream infections: A 6-year validated, population-based model. Clinical Infectious Diseases 24:1068-78.
  • Ramage G, Jose A, Coco B, Rajendran R, Rautemaa R, Murray C, Lappin D, Bagg J (2011). Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro. Oral Surgery Oral Medicine Oral Pathology Oral Radiology Endoddontics 111(4): 456-60.
  • Semighini CP, Hornby JM, Dumitru R, Nickerson KW, Haris SD (2006). Farnesol induced apoptosis in Aspergillus nidulans reveals a possible mechanism for antagonistic interactions between fungi. Moleculer Microbiology 59: 753-764.
  • Shchepin R, Dumitru R, Nickerson KW, Lund M, Dussault PH (2005). Biologically active fluorescent farnesol analogs. Chemistry Biological 12: 639-641.
  • Shchepin R, Hornby JM, Burger E, Niessen T, Dussault P, Nickerson KW (2003). Quorum sensing in Candida albicans: probing farnesol's mode of action with 40 natural and synthetic farnesol analogs. Chemistry Biological 10: 743-750.
  • Simões M, Simões LC, Vieira MJ (2010). A review of current and emergent biofilm control strategies. Food Science and Technology 43: 573-83.
  • Szafrański, SP, Winkel, A., Stiesch, M (2017). The use of bacteriophages to biocontrol oral biofilms. Journal of Biotechnology 250: 29-44.
  • Van Houdt R, Michiels CW (2010). Biofilm formation and the food industry, a fcus on the bacterial outer surface. Journal of Applied Microbiology 109: 1117-31.
  • Westwater C, Balish E, Schofield DA (2005). Candida albicans-conditioned medium protects yeast cells from oxidative stress: a possible link between quorum sensing and oxidative stress resistance. Eukaryot Cell 4: 1654-1661.
Toplam 26 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Yapısal Biyoloji
Bölüm Reviews
Yazarlar

Dilek Uzundağ 0000-0002-6256-574X

Ebru Şebnem Yılmaz 0000-0001-6124-4832

Hayri Baba 0000-0002-1837-4321

Yayımlanma Tarihi 15 Kasım 2020
Kabul Tarihi 26 Ekim 2020
Yayımlandığı Sayı Yıl 2020 Cilt: 4 Sayı: 2

Kaynak Göster

APA Uzundağ, D., Yılmaz, E. Ş., & Baba, H. (2020). Biofilm formation mechanism in fungi. Anatolian Journal of Botany, 4(2), 116-120. https://doi.org/10.30616/ajb.778072
AMA Uzundağ D, Yılmaz EŞ, Baba H. Biofilm formation mechanism in fungi. Ant J Bot. Kasım 2020;4(2):116-120. doi:10.30616/ajb.778072
Chicago Uzundağ, Dilek, Ebru Şebnem Yılmaz, ve Hayri Baba. “Biofilm Formation Mechanism in Fungi”. Anatolian Journal of Botany 4, sy. 2 (Kasım 2020): 116-20. https://doi.org/10.30616/ajb.778072.
EndNote Uzundağ D, Yılmaz EŞ, Baba H (01 Kasım 2020) Biofilm formation mechanism in fungi. Anatolian Journal of Botany 4 2 116–120.
IEEE D. Uzundağ, E. Ş. Yılmaz, ve H. Baba, “Biofilm formation mechanism in fungi”, Ant J Bot, c. 4, sy. 2, ss. 116–120, 2020, doi: 10.30616/ajb.778072.
ISNAD Uzundağ, Dilek vd. “Biofilm Formation Mechanism in Fungi”. Anatolian Journal of Botany 4/2 (Kasım 2020), 116-120. https://doi.org/10.30616/ajb.778072.
JAMA Uzundağ D, Yılmaz EŞ, Baba H. Biofilm formation mechanism in fungi. Ant J Bot. 2020;4:116–120.
MLA Uzundağ, Dilek vd. “Biofilm Formation Mechanism in Fungi”. Anatolian Journal of Botany, c. 4, sy. 2, 2020, ss. 116-20, doi:10.30616/ajb.778072.
Vancouver Uzundağ D, Yılmaz EŞ, Baba H. Biofilm formation mechanism in fungi. Ant J Bot. 2020;4(2):116-20.

Anadolu Botanik Dergisi CC BY 4.0cc.svg?ref=chooser-v1by.svg?ref=chooser-v1 ile lisanslıdır.